Pooled platelet concentrates: An alternative to single donor apheresis platelets?

Transfusion and Apheresis Science

Volumn 41, Issue 2, 2009, Pages 115-119

  Pietersz, R N I ^a  

^a Sanquin Bloedbank Regio Noordwest Amsterdam   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOCYTE CONCENTRATE;

ADVERSE OUTCOME; ARTICLE; BACTERIUM CONTAMINATION; BACTERIUM DETECTION; BLOOD DONOR; BLOOD PH; BLOOD SAMPLING; CELL ASSAY; DISINFECTION; DONOR SELECTION; HUMAN; PROCESSING; RECIPIENT; RISK REDUCTION; SHELF LIFE; STANDARDIZATION; STORAGE TEMPERATURE; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTE PRESERVATION; THROMBOCYTE RICH PLASMA; THROMBOCYTOPHERESIS; TOTAL QUALITY MANAGEMENT;

BLOOD COMPONENT REMOVAL; BLOOD PLATELETS; HUMANS; PLATELET COUNT; PLATELET TRANSFUSION; PLATELET-RICH PLASMA; PLATELETPHERESIS; PROSPECTIVE STUDIES;

EID: 70349208456     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2009.07.003     Document Type: Article

References (39)

1. Holme S., Sweeney J.D., Sawyer S., and Elfath M.D. The expression of p-selectin during collection, processing, and storage of platelet concentrates: relationship to loss of in vivo viability. Transfusion 37 (1997) 12-17
2. Standards for blood banks and transfusion services. AABB. 25th ed.; 2008.
3. Guide to the preparation, use and quality assurance of blood components. European directorate for the quality of medicines and healthcare of the council of Europe. 14th ed.; 2008.
4. Commission Directive 2004/33/EC of March 2004 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards certain technical requirements for blood and blood components. Official Journal of the European Union; March 2004.
5. Commission Directive 2005/62/EC of September 2005 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards Community standards and specifications relating to a quality system for blood establishments. Official Journal of the European Union; October 2005.
6. Guidance for Industry and FDA Review Staff. Collection of platelets by automated methods; December 2007. p. 1-34. .
7. for the NHLBI-REDS NAT Study Group, Busch M.P., Glynn S.A., Stramer S.L., Strong D.M., Caglioti S., Wright D.J., et al. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 45 (2005) 254-261
8. Blajchman M.A., Goldman M., and Baeza F. Improving the bacteriological safety of platelet transfusions. Transfus Med Rev 18 (2004) 11-24
9. McDonald C.P., Lowe P., Roy A., Robbins S., Hartley S., Harrison J.F., et al. Evaluation of donor arm disinfection techniques. Vox Sang 80 (2001) 135-141
10. De Korte D., Marcelis J.H., Verhoeven A.J., and Soeterboek A.M. Diversion of first blood volume results in reduction of bacterial contamination for whole-blood collections. Vox Sang 83 (2002) 13-16
11. McDonald C.P., Roy A., Mahajan P., et al. Relative values of the interventions of diversion and improved donor-arm disinfection to reduce the bacterial risk from blood transfusion. Vox Sang 86 (2004) 178-182
12. De Korte D., Curvers J., De Kort W.L.A.M., Hoekstra T., van der Poel C.L., Beckers E.A., et al. Effects of skin disinfection method, deviation bag, and bacterial screening on clinical safety of platelet transfusions in the Netherlands. Transfusion 46 (2006) 476-485
13. Benjamin R.J., Kline L., Dy B.A., Kennedy J., Pisciotto P., Sapatnekar S., et al. Bacterial contamination of whole blood-derived platelets: the introduction of sample diversion and prestorage pooling with culture testing in the American Red Cross. Transfusion 48 (2008) 2348-2355
14. International Forum. In: Pietersz R.N., Engelfriet C.P., and Reesink H.W. (Eds). Detection of bacterial contamination of platelet concentrates. Vox Sang 93 (2007) 260-277
15. Schrezenmeier H., Walther-Wenke G., Müller T.H., Weinauer F., Younis A., Holland-Letz T., et al. Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets. Transfusion 47 (2007) 644-652
16. Van der Meer P.F., and Pietersz R.N.I. Overnight storage of whole blood: a comparison of two designs of butane-1,4-diol cooling plates. Transfusion 47 (2007) 2038-2043
17. International Forum. In: Reesink H.W., and Engelfriet C.P. (Eds). What is the optimal storage temperature for whole blood prior to preparation of blood components. Vox Sang 65 (1993) 320-327
18. Kelley D.L., Fegan P.L., Ng A.T., et al. High yield platelet concentrates attainable by continuous improvement reduce platelet transfusion cost and donor exposure. Transfusion 37 (1997) 482-486
19. Muylle L., and Peetermans M.E. Effect of prestorage leukocyte removal on the cytokine levels in stored platelet concentrates. Vox Sang 66 (1994) 14-17
20. Heddle N.M., Blajchman M.A., Meyer R.M., Lipton J.H., Walker I.R., Sher G.D., et al. A randomized controlled trial comparing the frequency of acute reactions to plasma-removed platelets and prestorage WBC-reduced platelets. Transfusion 42 (2002) 556-566
21. Arnold D.M., Heddle N.M., Kulczyky M., Carruthers J., Sigouin C., and Blajchman M.A. In vivo recovery and survival of apheresis and whole blood-derived platelets: a paired comparison in healthy volunteers. Transfusion 46 (2006) 257-264
22. Sweeney J.D., Kouttab N.M., Holme S., Kurtis J.D., Cheves T.A., and Nelson E.J. Prestorage pooled whole-blood-derived leukoreduced platelets stored for seven days, preserve acceptable quality and do not show evidence of a mixed lymphocyte reaction. Transfusion 44 (2004) 1212-1219
23. ™ BC. Vox Sang 76 (1999) 231-236
24. for the BEST collaborative, and Murphy S. Platelets from pooled buffy coats: an update. Transfusion 45 (2005) 634-639
25. for the Biomedical Excellence for Safer Transfusion Working Party of the International Society of Blood Transfusion, Gulliksson H., AuBuchon J.P., Cardigan R., van der Meer P.F., Murphy S., Prowse C., et al. Storage of platelets in additive solutions: a multicentre study of the in vitro effects of potassium and magnesium. Vox Sang 85 (2003) 199-205
26. Larsson S., Sandgren P., Sjödin A., Vesterinen M., and Gulliksson H. Automated preparation of platelet concentrates from pooled buffy coats: in vitro studies and experiences with the OrbiSac system. Transfusion 45 (2005) 743-751
27. Sandgren P., Callaert M., Shanwell A., and Gulliksson H. Storage of platelet concentrates from pooled buffy coats made of fresh and overnight-stored whole blood processed on the novel Atreus 2C+ system: in vitro study. Transfusion 48 (2008) 688-696
28. Fijnheer R., Pietersz R.N., De Korte D., Gouwerok C.W., Dekker W.J., Reesink H.W., et al. Platelet activation during preparation of platelet concentrates: a comparison of the platelet-rich plasma and the buffy coat methods. Transfusion 30 (1990) 634-638
29. Skripchenko A., Kurtz J., Moroff G., and Wagner S.J. Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage. Transfusion 48 (2008) 1469-1477
30. Levin E., Culibrk B., Gyöngyössy-Issa M.I.C., Weiss S., Scammell K., LeFresne W., et al. Implementation of buffy coat platelet component production: comparison to platelet-rich plasma platelet production. Transfusion 48 (2008) 2331-2337
31. Bueno J.L., García F., Castro E., Barea L., and González R. A randomized crossover trial comparing three plateletpheresis machines. Transfusion 45 (2005) 1373-1381
32. Hagberg I.A., Akkøk C.A., Lyberg T., and Kjeldsen-Kragh J. Apheresis-induced platelet activation: comparison of three types of cell separators. Transfusion 40 (2000) 182-192
33. Holme S., Andres M., Goermar N., and Giordano G.F. Improved removal of white cells with minimal platelet loss by filtration of apheresis platelets during collection. Transfusion 39 (1999) 74-82
34. International Forum. In: Pietersz R.N., Engelfriet C.P., and Reesink H.W. (Eds). Evaluation of stored platelets. Vox Sang 86 (2004) 203-222
35. Dijkstra-Tiekstra M.J., Kuipers W., Setroikromo A.C., and de Wildt-Eggen J. Platelet capacity of various platelet pooling systems for buffy coat-derived platelet concentrates. Transfusion 48 (2008) 2114-2121
36. Dijkstra-Tiekstra M.J., Pietersz R.N.I., Hendriks E.C., Reesink H.W., and Huijgens P.C. In vivo PLT increments after transfusions of WBC-reduced PLT concentrates stored for up to 7 days. Transfusion 44 (2004) 330-336
37. Dumont L.J., Aubuchon J.P., Whitley P., et al. Seven-day storage of single-donor platelets: recovery and survival in an autologous transfusion study. Transfusion 42 (2002) 847-854
38. Cid J., and Lozano M. Lower or higher doses for prophylactic platelet transfusions: results of a meta-analysis of randomized controlled trials. Transfusion 47 (2007) 464-470
39. Heddle N.M., Arnold D.M., Boye D., Webert K.E., Resz I., and Dumont L.J. Comparing the efficacy and safety of apheresis and whole blood-derived platelet transfusions: a systematic review. Transfusion 48 (2008) 1447-1458